MyFinsight
Home
Compare
Blog
About
Seaport Therapeutics, Inc. (SPTX)
Seaport Therapeutics, Inc. (SPTX)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Cash Flow Overview
Change in Cash
$11,314K
Free Cash flow
-$26,141K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from initial public off...
Proceeds from maturities of inve...
Accrued expenses and other curre...
Others
Negative Cash Flow Breakdown
Purchase of investments
Prepaid expenses and other curre...
Net amortization of premium and ...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
Net loss
-62,600
-25,408
Stock-based compensation expense
36,863
2,569
Depreciation expense
26
26
Amortization of operating lease right-of-use assets
325
331
Net amortization of premium and discounts on investments
-359
-223
Prepaid expenses and other current assets
2,004
-1,571
Other non-current assets
0
0
Accounts payable
910
2,780
Related party payable
-11
4
Accrued expenses and other current liabilities
1,038
-1,499
Operating lease liability
-329
-323
Net cash used in operating activities
-26,141
-20,172
Purchase of investments
253,502
47,150
Proceeds from maturities of investments
50,000
75,000
Purchases of property and equipment
0
0
Net cash used in investing activities
-203,502
27,850
Proceeds from initial public offering, net of underwriting discounts and commissions and deferred offering costs
239,338
-
Payment of deferred offering costs
-
783
Proceeds from exercise of stock options
807
-
Net cash provided by financing activities
240,928
-783
Effect of exchange rates on cash and cash equivalents
29
-28
Net increase (decrease) in cash and cash equivalents
11,314
6,867
Cash, cash equivalents, and restricted cash, beginning of period
53,363
46,496
Cash, cash equivalents, and restricted cash, end of period
64,677
53,363
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from initial
public offering, net of...
$239,338K
Proceeds from exercise of
stock options
$807K
Net cash provided by
financing activities
$240,928K
Effect of exchange
rates on cash and cash...
$29K
Net increase
(decrease) in cash and cash...
$11,314K
Canceled cashflow
$229,643K
Proceeds from maturities
of investments
$50,000K
Stock-based compensation
expense
$36,863K
Accrued expenses and
other current...
$1,038K
Accounts payable
$910K
Amortization of operating
lease right-of-use...
$325K
Depreciation expense
$26K
Net cash used in
investing activities
-$203,502K
Net cash used in
operating activities
-$26,141K
Canceled cashflow
$50,000K
Canceled cashflow
$39,162K
Purchase of investments
$253,502K
Net loss
-$62,600K
Prepaid expenses and
other current assets
$2,004K
Net amortization of
premium and discounts on...
-$359K
Operating lease liability
-$329K
Related party payable
-$11K
Buy us a coffee